MCMedicalCodingSoftware
Free trial
XW0DX38

XW0DX38 — Introduction of Maribavir Anti-infective into Mouth and Pharynx, External Approach, New Technology Group 8

Billable / specific codeICD-10-PCS

CMS abbreviated title: Introduce Maribavir in Mouth/Phar, Extern, New Tech 8

How XW0DX38 is built

Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.

  1. XSectionNew Technology — What family of procedure this is
  2. WBody systemWhich system it acts on
  3. 0Root operationThe objective — the verb of the procedure
  4. DBody partThe specific site
  5. XApproachHow the site was reached
  6. 3DeviceWhat was left in place, if anything
  7. 8QualifierA further distinction where one applies

Codes near XW0DX38

In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.

  • XW043Q9Introduction of Posoleucel into Central Vein, Percutaneous Approach, New Technology Group 9
  • XW043QBIntroduction of Iloprost into Central Vein, Percutaneous Approach, New Technology Group 11
  • XW043R9Introduction of Rezafungin into Central Vein, Percutaneous Approach, New Technology Group 9
  • XW043RBIntroduction of Letetresgene Autoleucel into Central Vein, Percutaneous Approach, New Technology Group 11
  • XW043S5Introduction of Iobenguane I-131 Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 5
  • XW043W5Introduction of Caplacizumab into Central Vein, Percutaneous Approach, New Technology Group 5
  • XW043WBIntroduction of Fosfomycin Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 11
  • XW053T9Introduction of Melphalan Hydrochloride Antineoplastic into Peripheral Artery, Percutaneous Approach, New Technology Group 9
  • XW0DX38Introduction of Maribavir Anti-infective into Mouth and Pharynx, External Approach, New Technology Group 8
  • XW0DX82Introduction of Uridine Triacetate into Mouth and Pharynx, External Approach, New Technology Group 2
  • XW0DXF5Introduction of Other New Technology Therapeutic Substance into Mouth and Pharynx, External Approach, New Technology Group 5
  • XW0DXJ9Introduction of Quizartinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 9
  • XW0DXK8Introduction of Sabizabulin into Mouth and Pharynx, External Approach, New Technology Group 8
  • XW0DXM6Introduction of Baricitinib into Mouth and Pharynx, External Approach, New Technology Group 6
  • XW0DXN9Introduction of SER-109 into Mouth and Pharynx, External Approach, New Technology Group 9
  • XW0DXR7Introduction of Fostamatinib into Mouth and Pharynx, External Approach, New Technology Group 7
  • XW0DXVBIntroduction of Xanomeline and Trospium Chloride into Mouth and Pharynx, External Approach, New Technology Group 11
ICD-10-PCSFY2026